APX2009 is a second-generation APE1/Ref-1 redox-specific inhibitor. APX2009 significantly reduces NFkB transcriptional activity, survivin mRNA, and survivin protein levels. APX2009 decreases prostate cancer cell proliferation and induces cell cycle arrest.
Molecular Weight:
355.43
CAS Number:
[1415030-15-7]
Formula:
C21H25NO4
Target:
Others|||Apoptosis
T70733
* VAT and and shipping costs not included. Errors and price changes excepted
